首页> 美国卫生研究院文献>other >Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years
【2h】

Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years

机译:改良肾zhu方药治疗两年显性蛋白尿糖尿病肾病的回顾性分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of the present study was to evaluate the 2-year effectiveness of modified Shenzhuo formula in the treatment of overt proteinuria diabetic kidney disease (DKD).Patients diagnosed with type 2 DKD in the clinical research database of Prof Xiaolin Tong (>20,000 data points) with >1-year follow-up were screened for this study. Patients’ demographic data, chief complaint, present illness, past history, allergic history, personal history, family history, test results, tongue images, pulse information, and prescription information at 1, 1.5, and 2 years of follow-up were analyzed. EpiData3.1 was used to establish the electronic database of this research and SPSS v20.0 (SPSS Inc, Chicago, IL) was used for performing statistical analyses.The patients’ common main symptoms of overt proteinuria DKD were weak breath and fatigue, numbness of limbs, insomnia, blurred vision, nocturia, edema, low backache, constipation, itchy skin ulcer, and chills. The average 24-hour urinary protein of patients treated with modified Shenzhuo formula was statistically significantly lower than baseline values at 1, 1.5, and 2 years (0.66 g, 95% confidence interval [CI] [−0.95, −0.41]; 1.00 g, 95% CI [−1.67, 0.38]; 1.11 g, 95% CI [−1.79, −0.57]). There are no statistically significant differences between the glomerular filtration rate at the baseline and that after modified Shenzhuo formula intervention. Statistically significant reductions in serum triglyceride and glycosylated hemoglobin values and systolic blood pressure also were recorded. Other indexes, including serum creatinine, blood urea nitrogen, diastolic blood pressure, cholesterol, high-density lipoprotein, and low-density lipoproteins, did not differ between baseline and post-treatment time points.Modified Shenzhuo formula could reduce 24-hour urinary protein excretion in patients with DKD. The formula maybe had the potential advantages on glomerular filtration rate, creatinine reciprocal, blood lipid levels, etc.
机译:本研究的目的是评估改良的神zhu配方治疗明显的蛋白尿糖尿病性肾脏病(DKD)的2年有效性。童晓林教授的临床研究数据库中诊断出患有2型DKD的患者(> 20,000数据随访1年以上)。在随访的1年,1.5年和2年,分析了患者的人口统计学数据,主要主诉,当前疾病,既往史,过敏史,个人史,家庭史,检查结果,舌头图像,脉搏信息和处方信息。使用EpiData3.1建立本研究的电子数据库,并使用SPSS v20.0(SPSS Inc,Chicago,IL)进行统计分析。患者明显蛋白尿DKD的常见主要症状是呼吸困难和疲劳,麻木四肢,失眠,视力模糊,夜尿症,水肿,腰酸,便秘,皮肤溃疡,发冷。用改良的Shenzhuo配方治疗的患者的平均24小时尿蛋白在统计学上显着低于1、1.5和2年的基线值(0.66μg,95%置信区间[CI] [-0.95,-0.41];1.00μg ,95%CI [-1.67,0.38]; 1.11 g,95%CI [-1.79,-0.57]。基线时的肾小球滤过率与改良的Shenzhuo公式干预后的肾小球滤过率之间无统计学差异。还记录了血清甘油三酸酯和糖基化血红蛋白值以及收缩压的统计学显着降低。其他指标包括血清肌酐,血尿素氮,舒张压,胆固醇,高密度脂蛋白和低密度脂蛋白在基线和治疗后的时间点之间没有差异。改良的神zhu配方可以减少24小时尿蛋白DKD患者排泄。该配方在肾小球滤过率,肌酐倒数,血脂水平等方面可能具有潜在的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号